Samanta Salvi

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS

Affiliated withIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS

Research Area

Biography

Samanta Salvi has not added Biography.
If you are Samanta Salvi and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 3	Year
Publication title Cited by 16	2017
Publication title Cited by 4	2017
Publication title	2018

Other Publications

Article	Year
Urine cell-free DNA integrity as a marker for early prostate cancer diagnosis: a pilot study. BioMed research international\| PubMed ID: 23509700	2013
Copy number analysis of 24 oncogenes: MDM4 identified as a putative marker for low recurrence risk in non muscle invasive bladder cancer. International journal of molecular sciences\| PubMed ID: 25026175	2014
Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients. Disease markers\| PubMed ID: 26412928	2015
Impact of Candidate Genetic Polymorphisms in Prostate Cancer: An Overview. Molecular diagnosis & therapy\| PubMed ID: 26518421	2016
Plasma AR and abiraterone-resistant prostate cancer. Science translational medicine\| PubMed ID: 26537258	2015
CYP17A1 polymorphisms and clinical outcome of castration-resistant prostate cancer patients treated with abiraterone. The International journal of biological markers\| PubMed ID: 26954071	2016
Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy\| PubMed ID: 27177757	2016
Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer. Oncotarget\| PubMed ID: 27191887	2016
miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer. OncoTargets and therapy\| PubMed ID: 27226732	2016
Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach. Journal of translational medicine\| PubMed ID: 27576364	2016
GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications. Disease markers\| PubMed ID: 27594734	2016
The potential use of urine cell free DNA as a marker for cancer. Expert review of molecular diagnostics\| PubMed ID: 27796148	2016
Cell-free DNA as a diagnostic marker for cancer: current insights. OncoTargets and therapy\| PubMed ID: 27822059	2016
Digital PCR identifies changes in CDH1 (E-cadherin) transcription pattern in intestinal-type gastric cancer. Oncotarget\| PubMed ID: 27861150	2016
Vitamin D status among long-term survivors of testicular cancer. Oncotarget\| PubMed ID: 28030821	2016
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer. Oncotarget\| PubMed ID: 28186965	2017
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nature communications\| PubMed ID: 29180617	2017
Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nature communications\| PubMed ID: 29311577	2018